Glitazones are known for their antidiabetic action and belong to a group of synthetic compounds which act as agonists of PPARγ and improve insulin sensitivity and reduce the blood glucose levels in patients with type 2 diabetes [56]. The gene discussed is INS; the disease is type 2 diabetes mellitus.